<?xml version="1.0" encoding="UTF-8"?>
<p>The primary study objective was to evaluate the safety and tolerability of a single intravenous infusion of hUCB‚ÄêMSCs in study subjects. The secondary objective was to obtain a preliminary assessment of its efficacy. For the efficacy end points, changes of DAS28 and HAQ 4 weeks after the infusion were evaluated.</p>
